Mitochondria

The secret chamber of therapeutic targets for age-associated degenerative diseases

Youngmi Kim Pak, Jae Hoon Jeong

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Mitochondria have long been recognized as ATP engines for the cell and recently as a dynamic and mobile organelles that control cell death and life. This exquisite organelle is the site of reactive oxygen species production and is highly vulnerable to exogenous stresses, resulting in catastrophic damage to the cell. Mitochondrial dysfunction is linked to a wide range of age-associated degenerative diseases, such as metabolic syndrome, cardiovascular disease, and neurodegenerative diseases. Understanding the molecular mechanisms of mitochondria-dependent pathogenesis may provide important strategies to treat these diseases. Indeed, mitochondria are emerging therapeutic targets for the mitochondria-related diseases. In this paper, we review the recent concepts of mitochondrial biology and how mitochondria are involved in ageassociated degenerative diseases. Furthermore, we summarize the therapeutics which target to improve mitochondrial functions.

Original languageEnglish (US)
Pages (from-to)235-245
Number of pages11
JournalBiomolecules and Therapeutics
Volume18
Issue number3
DOIs
StatePublished - Jul 1 2010
Externally publishedYes

Fingerprint

Mitochondria
Organelles
Neurodegenerative diseases
Therapeutics
Cell death
Neurodegenerative Diseases
Reactive Oxygen Species
Cell Death
Cardiovascular Diseases
Adenosine Triphosphate
Engines

Keywords

  • Degenerative disease
  • Mitochondria
  • Mitochondrial medicine
  • Therapeutic

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

Mitochondria : The secret chamber of therapeutic targets for age-associated degenerative diseases. / Pak, Youngmi Kim; Jeong, Jae Hoon.

In: Biomolecules and Therapeutics, Vol. 18, No. 3, 01.07.2010, p. 235-245.

Research output: Contribution to journalReview article

@article{d4ca6482419a4285888b34039e8b125a,
title = "Mitochondria: The secret chamber of therapeutic targets for age-associated degenerative diseases",
abstract = "Mitochondria have long been recognized as ATP engines for the cell and recently as a dynamic and mobile organelles that control cell death and life. This exquisite organelle is the site of reactive oxygen species production and is highly vulnerable to exogenous stresses, resulting in catastrophic damage to the cell. Mitochondrial dysfunction is linked to a wide range of age-associated degenerative diseases, such as metabolic syndrome, cardiovascular disease, and neurodegenerative diseases. Understanding the molecular mechanisms of mitochondria-dependent pathogenesis may provide important strategies to treat these diseases. Indeed, mitochondria are emerging therapeutic targets for the mitochondria-related diseases. In this paper, we review the recent concepts of mitochondrial biology and how mitochondria are involved in ageassociated degenerative diseases. Furthermore, we summarize the therapeutics which target to improve mitochondrial functions.",
keywords = "Degenerative disease, Mitochondria, Mitochondrial medicine, Therapeutic",
author = "Pak, {Youngmi Kim} and Jeong, {Jae Hoon}",
year = "2010",
month = "7",
day = "1",
doi = "10.4062/biomolther.2010.18.3.235",
language = "English (US)",
volume = "18",
pages = "235--245",
journal = "Biomolecules and Therapeutics",
issn = "1976-9148",
publisher = "Korean Society of Applied Pharmacology",
number = "3",

}

TY - JOUR

T1 - Mitochondria

T2 - The secret chamber of therapeutic targets for age-associated degenerative diseases

AU - Pak, Youngmi Kim

AU - Jeong, Jae Hoon

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Mitochondria have long been recognized as ATP engines for the cell and recently as a dynamic and mobile organelles that control cell death and life. This exquisite organelle is the site of reactive oxygen species production and is highly vulnerable to exogenous stresses, resulting in catastrophic damage to the cell. Mitochondrial dysfunction is linked to a wide range of age-associated degenerative diseases, such as metabolic syndrome, cardiovascular disease, and neurodegenerative diseases. Understanding the molecular mechanisms of mitochondria-dependent pathogenesis may provide important strategies to treat these diseases. Indeed, mitochondria are emerging therapeutic targets for the mitochondria-related diseases. In this paper, we review the recent concepts of mitochondrial biology and how mitochondria are involved in ageassociated degenerative diseases. Furthermore, we summarize the therapeutics which target to improve mitochondrial functions.

AB - Mitochondria have long been recognized as ATP engines for the cell and recently as a dynamic and mobile organelles that control cell death and life. This exquisite organelle is the site of reactive oxygen species production and is highly vulnerable to exogenous stresses, resulting in catastrophic damage to the cell. Mitochondrial dysfunction is linked to a wide range of age-associated degenerative diseases, such as metabolic syndrome, cardiovascular disease, and neurodegenerative diseases. Understanding the molecular mechanisms of mitochondria-dependent pathogenesis may provide important strategies to treat these diseases. Indeed, mitochondria are emerging therapeutic targets for the mitochondria-related diseases. In this paper, we review the recent concepts of mitochondrial biology and how mitochondria are involved in ageassociated degenerative diseases. Furthermore, we summarize the therapeutics which target to improve mitochondrial functions.

KW - Degenerative disease

KW - Mitochondria

KW - Mitochondrial medicine

KW - Therapeutic

UR - http://www.scopus.com/inward/record.url?scp=77957372038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957372038&partnerID=8YFLogxK

U2 - 10.4062/biomolther.2010.18.3.235

DO - 10.4062/biomolther.2010.18.3.235

M3 - Review article

VL - 18

SP - 235

EP - 245

JO - Biomolecules and Therapeutics

JF - Biomolecules and Therapeutics

SN - 1976-9148

IS - 3

ER -